Showing results (141-150 of 610) with videos related to
Sort By:
Pageof 61
Thrombosis and Haemostasis|March 28, 2002
Adipocyte hypertrophy in stromelysin-3 deficient mice with nutritionally induced obesityH R Lijnen, Hoef B Van, L Frederix, et al.Biochimica Et Biophysica Acta|September 4, 1992
Biochemical properties of recombinant mutants of nonglycosylated single chain urokinase-type plasminogen activatorX K Li, H R Lijnen, L Nelles, et al.Thrombosis and Haemostasis|June 12, 1999
Temporal and topographic matrix metalloproteinase expression after vascular injury in miceH R Lijnen, F Lupu, L Moons, et al.Biochimica Et Biophysica Acta|September 9, 1980
Kinetic properties of tripeptide lysyl chloromethyl ketone and lysyl p-nitroanilide derivatives towards trypsin-like serine proteinasesD Collen, H R Lijnen, F De Cock, et al.Circulation|November 1, 1990
Thrombolytic and pharmacokinetic properties of a conjugate of recombinant single-chain urokinase-type plasminogen activator with a monoclonal antibody specific for cross-linked fibrin in a baboon venous thrombosis modelD Collen, M Dewerchin, H J Rapold, et al.European Journal of Biochemistry|April 15, 1992
Biochemical properties of recombinant single-chain urokinase-type plasminogen activator mutants with deletion of Asn2 through Phe157 and/or substitution of Cys279 with AlaH R Lijnen, X K Li, L Nelles, et al.Thrombosis and Haemostasis|August 6, 2000
Plasminogen binding properties of macrophage inflammatory protein (MIP)-2alphaB Arza, J Félez, P Fábregas, et al.Thrombosis and Haemostasis|January 1, 1994
Expression and characterization of clustered charge-to-alanine mutants of low M(r) single-chain urokinase-type plasminogen activatorS Ueshima, P Holvoet, H R Lijnen, et al.Thrombosis and Haemostasis|August 20, 1986
Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitroD Collen, F De Cock, E Demarsin, et al.Circulation|September 1, 1991
Thrombolytic and pharmacokinetic properties of chimeric tissue-type and urokinase-type plasminogen activatorsD Collen, H R Lu, H R Lijnen, et al.Pageof 61